Pharmaceutical Executive Daily: Angelini Pharma Acquires Catalyst Pharmaceuticals in $4.1 Billion Agreement
Strengthening the Generic Drugs Supply Chain
Pharmaceutical Executive Daily: Zentalis Doses First Patient with Azenosertib in Phase III Trial
Pharmaceutical Executive Daily: BioNTech Reports 2026 First Quarter Results
Pharmaceutical Executive Daily: UCB to Acquire Candid Therapeutics
Pharmaceutical Executive Daily: FDA Approves Auvelity
Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO
Pharmaceutical Executive Daily: Rocket Pharmaceuticals Sells Pediatric Disease Priority Review Voucher
Pharmaceutical Executive Daily: FDA Approves Breztri
Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia
Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie
Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent
The Ron Lanton Report: Where Innovations Happens
Pharmaceutical Executive Daily: Idvynso Receives FDA Approval
Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
Pharmaceutical Executive Daily: Eli Lilly Releases Updated Safety Data for Foundayo
Pharmaceutical Executive Daily: Obsidian and Galera Therapeutics Enter Merger Agreement
Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement
Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
Why Branding is Pharma’s Most Undervalued Asset
Pharmaceutical Executive Daily: Shionogi Receives a Contract Through BARDA's Project BioShield
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
Pharmaceutical Executive Daily: Wegovy HD Now Available in the U.S.
Pharmaceutical Executive Daily: Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics
Pharmaceutical Executive Daily: President Trump Imposes 100% Tariff for Branded Pharmaceuticals
Pharmaceutical Executive Daily: Leadership Turnover Under Trump Administration
Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul
Pharmaceutical Executive Daily: Novo Nordisk's Wegovy Subscription Program
Pharmaceutical Executive Daily: Eli Lilly Presses U.K. Government to Raise NHS Drug Pricing
Pharmaceutical Executive Daily: Novartis Acquires Excellergy Inc.
Pharmaceutical Executive Daily: Trump Administration Misses Deadline to Nominate Permanent CDC Director
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
Pharmaceutical Executive Daily: Bayer Shares Drop After Inclusive Capital Offloads Remaining Stake
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
The Ron Lanton Report: When Policy Becomes a Capital Event
Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing
Pharmaceutical Executive Daily: Federal Judge Halts Vaccine Advisory Council Appointments
Pharmaceutical Executive Daily: Conflict in Middle East Disrupts Pharma Supply Chains
Pharmaceutical Executive Daily: FDA Expands Approval for Arexvy
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
Moving CAR-T Beyond Oncology
Pharmaceutical Executive Daily: FDA's New Guidance for Biosimilar Development
Pharmaceutical Executive Daily: FDA Expands Approval of Leucovorin
Pharmaceutical Executive Daily: Vinay Prasad Set to Leave CBER for Second Time
Pharmaceutical Executive Daily: Cognito Therapeutics and Nexcure Secure Financing Rounds
Pharmaceutical Executive Daily: Pharma Industry's AI Adoption
next page